{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:16:07Z","timestamp":1790997367982,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiologic Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rcl.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:30:29Z","timestamp":1771590629000},"page":"537-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ovarian Cancer Screening and Ovarian-Adnexal Reporting and Data System"],"prefix":"10.1016","volume":"64","author":[{"given":"Yang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul B.","family":"Shinagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash R.","family":"Kambadakone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine S.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.rcl.2026.01.007_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1055\/a-2589-5696","article-title":"Ovarian cancer screening: recommendations and future prospects","volume":"197","author":"Chiu","year":"2025","journal-title":"Rofo"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1148\/rg.2021200086","article-title":"Multimodality imaging approach to ovarian neoplasms with pathologic correlation","volume":"41","author":"Taylor","year":"2021","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/j.rcl.2026.01.007_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11912-019-0816-0","article-title":"Novel approaches to ovarian cancer screening","volume":"21","author":"Nebgen","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-022-01588-8","article-title":"Potential clinical utility of liquid biopsies in ovarian cancer","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol Cancer"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.007_bib6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.rcl.2017.06.010","article-title":"Imaging and screening of ovarian cancer","volume":"55","author":"Lowry","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.007_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6729","article-title":"BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer","volume":"13","author":"Richau","year":"2024","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.rcl.2026.01.007_bib8","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.3390\/ijms26104611","article-title":"Ovarian Cancer-Epidemiology, classification, pathogenesis, treatment, and Estrogen receptors\u2019 molecular backgrounds","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.rcl.2026.01.007_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.007_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/diagnostics10020102","article-title":"Serous tubal intraepithelial carcinoma: a concise review for the practicing pathologist and clinician","volume":"10","author":"Bachert","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/AOG.0000000000003165","article-title":"774 summary: opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib12","doi-asserted-by":"crossref","first-page":"pky061","DOI":"10.1093\/jncics\/pky061","article-title":"Population frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in clinical practice using SEE-Fim protocol","volume":"2","author":"Samimi","year":"2018","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-021-03244-w","article-title":"Recommendations for diagnosing STIC: a systematic review and meta-analysis","volume":"480","author":"Bogaerts","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.rcl.2026.01.007_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.951292","article-title":"Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: a systematic review of the literature","volume":"12","author":"Linz","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.007_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jmig.2020.09.020","article-title":"Salpingectomy for the risk reduction of ovarian cancer: is it time for a salpingectomy-alone approach?","volume":"28","author":"Boerner","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"issue":"8","key":"10.1016\/j.rcl.2026.01.007_bib16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.007_bib17","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.223281","article-title":"Adnexal lesion imaging: past, present, and future","volume":"307","author":"Sadowski","year":"2023","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.007_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/cells11030539","article-title":"Hereditary ovarian carcinoma: cancer pathogenesis looking beyond BRCA1 and BRCA2","volume":"11","author":"Samuel","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.rcl.2026.01.007_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement","volume":"322","author":"Force","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.rcl.2026.01.007_bib21","unstructured":"NCCN. Genetic\/familial high-risk assessment: breast, ovarian, pancreatic, prostate. Version 2. 2026. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1545."},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18632\/oncotarget.12306","article-title":"Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"57","key":"10.1016\/j.rcl.2026.01.007_bib23","doi-asserted-by":"crossref","first-page":"97657","DOI":"10.18632\/oncotarget.18280","article-title":"BRCA mutations in the manifestation and treatment of ovarian cancer","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10689-021-00264-y","article-title":"Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group","volume":"20","author":"Bakhuizen","year":"2021","journal-title":"Fam Cancer"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.007_bib25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast","year":"1981","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.rcl.2026.01.007_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/diagnostics14090949","article-title":"Sensitivity and specificity of selected biomarkers and their combinations in the diagnosis of ovarian cancer","volume":"14","author":"Englisz","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1158\/2159-8290.CD-24-0393","article-title":"Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers","volume":"15","author":"Medina","year":"2025","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jog.14654","article-title":"Application of serum markers in diagnosis and staging of ovarian endometriosis","volume":"47","author":"Tang","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.007_bib29","first-page":"341","article-title":"Pelvic inflammatory disease. Correlation of severity with CA-125 levels","volume":"41","author":"Moley","year":"1996","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.007_bib30","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1148\/rg.2021210005","article-title":"Past, present, and future of serum tumor markers in management of ovarian cancer: a guide for the radiologist","volume":"41","author":"Rao","year":"2021","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib31","article-title":"Comparative meta-analysis of carbohydrate antigen 125 (CA125), human epididymis protein 4 (HE4), and diagnostic indices (risk of malignancy index (RMI) and risk of ovarian malignancy Algorithm (ROMA)) for pre-operative detection of ovarian carcinoma","volume":"17","author":"Singh","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.rcl.2026.01.007_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104263","article-title":"The role of liquid biopsy in epithelial ovarian cancer: state of the art","volume":"194","author":"Della Corte","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10022","key":"10.1016\/j.rcl.2026.01.007_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"issue":"9160","key":"10.1016\/j.rcl.2026.01.007_bib35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","article-title":"Screening for ovarian cancer: a pilot randomised controlled trial","volume":"353","author":"Jacobs","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.007_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ygyno.2013.06.029","article-title":"Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis","volume":"130","author":"Reade","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.007_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"issue":"10290","key":"10.1016\/j.rcl.2026.01.007_bib38","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"issue":"5S","key":"10.1016\/j.rcl.2026.01.007_bib39","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1016\/j.jacr.2025.02.016","article-title":"ACR appropriateness Criteria(R) ovarian cancer screening: 2024 update","volume":"22","author":"Venkatesan","year":"2025","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.007_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer: US preventive services task force recommendation statement","volume":"319","author":"Force","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/medicina61040679","article-title":"Diagnostic performance of gynecologic imaging reporting and data system (GI-RADS) in preoperative evaluation of adnexal masses","volume":"61","author":"Taha","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2019191150","article-title":"O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee","volume":"294","author":"Andreotti","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.007_bib44","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230685","article-title":"O-RADS US v2022: an update from the American college of radiology\u2019s ovarian-adnexal reporting and data system US committee","volume":"308","author":"Strachowski","year":"2023","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.rcl.2026.01.007_bib45","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajog.2016.01.007","article-title":"Predicting the risk of malignancy in adnexal masses based on the simple rules from the international ovarian tumor analysis group","volume":"214","author":"Timmerman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rcl.2026.01.007_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5920","article-title":"Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study","volume":"349","author":"Van Calster","year":"2014","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.rcl.2026.01.007_bib47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jacr.2018.07.004","article-title":"Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR Ovarian-Adnexal Reporting and Data System Committee","volume":"15","author":"Andreotti","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/08465371221108057","article-title":"The Ovarian\/Adnexal reporting and data system for ultrasound: from standardized terminology to optimal risk assessment and management","volume":"74","author":"Phillips","year":"2023","journal-title":"Can Assoc Radiol J"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.007_bib49","doi-asserted-by":"crossref","first-page":"e2216370","DOI":"10.1001\/jamanetworkopen.2022.16370","article-title":"Diagnostic performance of the ovarian-adnexal reporting and data system (O-RADS) ultrasound risk score in women in the United States","volume":"5","author":"Jha","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.007_bib50","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00330-020-07143-7","article-title":"Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses","volume":"31","author":"Basha","year":"2021","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1148\/radiol.211868","article-title":"External validation of O-RADS US risk stratification and management system","volume":"304","author":"Hack","year":"2022","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.007_bib52","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.223269","article-title":"O-RADS US: a systematic review and meta-analysis of category-specific malignancy rates","volume":"308","author":"Lee","year":"2023","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.rcl.2026.01.007_bib53","first-page":"559","article-title":"Variations in mortality of the coloured, white and Asian population groups in the RSA, 1978-1982. Part IV. Respiratory diseases","volume":"72","author":"Epstein","year":"1987","journal-title":"S Afr Med J"},{"key":"10.1016\/j.rcl.2026.01.007_bib54","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-025-04813-2","article-title":"Inter-reader reliability of Ovarian-Adnexal Reporting and Data System US: a systematic review and meta-analysis","author":"Bae","year":"2025","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"10.1016\/j.rcl.2026.01.007_bib55","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1007\/s00330-024-11235-z","article-title":"Ovarian-adnexal imaging-reporting and data system (O-RADS) ultrasound version 2019: a prospective validation and comparison to updated version (v2022) in pathologically confirmed adnexal masses","volume":"35","author":"Almalki","year":"2025","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib56","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240044","article-title":"The ovarian-adnexal reporting and data system (O-RADS) US score effect on surgical resection rate","volume":"313","author":"Shen","year":"2024","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2214\/AJR.22.28084","article-title":"O-RADS MRI after initial ultrasound for adnexal lesions: AJR expert panel narrative review","volume":"220","author":"Sadowski","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib58","doi-asserted-by":"crossref","first-page":"e1919896","DOI":"10.1001\/jamanetworkopen.2019.19896","article-title":"Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses","volume":"3","author":"Thomassin-Naggara","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.007_bib59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jacr.2020.12.022","article-title":"Ovarian-adnexal reporting lexicon for MRI: a white paper of the ACR ovarian-adnexal reporting and data systems MRI committee","volume":"18","author":"Reinhold","year":"2021","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiol.204371","article-title":"O-RADS MRI risk stratification system: guide for assessing adnexal lesions from the ACR O-RADS committee","volume":"303","author":"Sadowski","year":"2022","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2214\/AJR.22.28396","article-title":"Systematic review and meta-analysis of O-RADS ultrasound and O-RADS MRI for risk assessment of ovarian and adnexal lesions","volume":"221","author":"Zhang","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib62","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220795","article-title":"O-RADS MRI: a systematic review and meta-analysis of diagnostic performance and category-wise malignancy rates","volume":"307","author":"Rizzo","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.12.033","article-title":"Quality of care in advanced ovarian cancer: the importance of provider specialty","volume":"117","author":"Mercado","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.rcl.2026.01.007_bib64","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ygyno.2007.02.030","article-title":"The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review","volume":"105","author":"Vernooij","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.rcl.2026.01.007_bib65","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233332","article-title":"The roles of ovarian-adnexal reporting and data system US and ovarian-adnexal reporting and data system MRI in the evaluation of adnexal lesions","volume":"312","author":"Patel-Lippmann","year":"2024","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.rcl.2026.01.007_bib66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/02841851241297201","article-title":"Diagnostic value of contrast-enhanced ultrasound in ovarian cancer: a meta-analysis","volume":"66","author":"Li","year":"2025","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2026.01.007_bib67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41591-024-03329-4","article-title":"International multicenter validation of AI-driven ultrasound detection of ovarian cancer","volume":"31","author":"Christiansen","year":"2025","journal-title":"Nat Med"}],"container-title":["Radiologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838926000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838926000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:20:49Z","timestamp":1778833249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033838926000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0033838926000072"],"URL":"https:\/\/doi.org\/10.1016\/j.rcl.2026.01.007","relation":{},"ISSN":["0033-8389"],"issn-type":[{"value":"0033-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian Cancer Screening and Ovarian-Adnexal Reporting and Data System","name":"articletitle","label":"Article Title"},{"value":"Radiologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcl.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}